Navigation Links
Give the Gift of Love With Women's Intimacy Product that Increases Pleasure for Both Partners
Date:11/20/2007

Non-Prescription Zestra Can Be Anti-Aging Solution for Baby Boomers In

Search of Better Sex

NEW YORK, Nov. 20 /PRNewswire/ -- People hope to buy gifts during the holidays that recipients will love. But one product is, in many ways, the gift of love itself.

(Photo: http://www.newscom.com/cgi-bin/prnh/20040309/CLTUFNS1 )

To view the Multimedia News Release, go to:

http://www.prnewswire.com/mnr/zestra/30486/

Zestra(R) (http://www.zestra.com) is the only clinically proven women's intimacy product that increases pleasure for both partners. The Zestra topically applied solution - which is available without a prescription -- now gives most women an answer for their sexual problems, much as the popular erectile dysfunction drugs have done for men in recent years, says Zestra's inventor, Martin Crosby.

"About 43 percent of American women suffer from female sexual dysfunction and these problems often occur in combination with menopause, depression, diabetes, and troublesome sexual side effects of many prescription drugs," Crosby says. "Now women have a quick proven solution for enjoying and restoring a healthy sex life which for most couples, enhances their overall quality of life by turning back their 'intimacy clock' several years."

Women using Zestra, and especially baby-boomers, quickly discover it becomes their 'anti-aging' solution for enjoying more satisfying sexual experiences. This kind of approach can also be useful to better optimize your copy for search purposes. The above is just a suggestion, but the more we can make the copy read more like an article and less like a press release, the better your chances of garnering more media pickup and attention.

The leading women's intimacy product in the United States, Zestra stands alone as the only non-hormonal, clinically studied intimacy product that effectively addresses female sexual problems. Research shows Zestra not only improves the sexual experience of women who have sexual difficulties, including those taking SSRI antidepressants, but also enhances the intimacy experience for women without sexual difficulties. "Zestra gives women of all ages a fluid that assists with arousal, pleasure and satisfaction - and that can translate into better relationships," Crosby said.

Backed by scientific findings, leading sexual health experts, and no need for a physician's prescription, gift givers can grant a new level of pleasure to their female loved one this holiday. "Women want rewarding intimate relationships, and with Zestra, passion warms the hearts of women and their partners during the holidays and throughout the year," Crosby said.

About Zestra(R) Feminine Arousal Fluid (U.S. Patent 6,737,084; EP Patent EP1328281)

Zestra Laboratories, Inc., a specialty consumer health products company, is developer and manufacturer of Zestra(R) Feminine Arousal Fluid, a patented, all-natural formulation of two botanical oils and two extracts. It is the only consumer product clinically shown to quickly increase female sexual sensation, arousal, pleasure and desire. Non-prescription Zestra(R) does not contain potentially harmful synthetics, hormones or parabens.

Zestra(R), the result of seven years of research and clinical testing, has shown to be effective in both Phase II-type and Phase III-type, FDA-quality studies for women who have sexual difficulties, including those taking SSRI antidepressants, and to enhance the intimacy experience for women without sexual difficulties. In 2006, Zestra(R) became the leading women's intimacy product sold in the United States. It is available at about 40,000 pharmacies and select supermarkets, including those in Canada, the United Kingdom, China, Mexico, and 11 other countries. For more information, visit http://www.zestra.com.

Kristie Bohm Byrum, APR

Zestra/Byrum Innovation Group

864.242.1102

kristiebyrum@byruminnovation.com


'/>"/>
SOURCE Zestra Laboratories, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
3. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
4. Three Batesville Casket Company Production Facilities Honored for Manufacturing Expertise by National Organizations
5. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
6. End-to-End HR Performance Benchmarks: Metrics That Will Help Turn the HR Cost Center into a Productivity Driver
7. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
8. Drug Detection Kits Manufactured By IDenta Corp. Shown During French Television Broadcast (at TF1) - Product Aids French Police In Bust of 600 Kilograms Of Cocaine
9. Why Are Most Health & Wellness Products Doomed to Failure?
10. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
11. GladRags Introduces the Moon Cup - An Environmentally-Sound and Safe Alternative to Disposable Feminine Hygiene Products!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... Children exposed to secondhand marijuana ... the Icahn School of Medicine at Mount Sinai has found. The study was ... children are exposed to secondhand marijuana smoke, measurable amounts of primary metabolite of ...
(Date:12/7/2016)... ... December 07, 2016 , ... Wavelink, ... Device Remote Control through a new partnership with Splashtop Inc. This remote control ... mobile solutions to help businesses maximize their uptime and productivity. , Wavelink offers ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... S.L. (“Presence”) for a purchase price of approximately $17.4 million (net of ... annual revenue is approximately $13.2 million. Headquartered in Barcelona, Spain, Presence is ...
(Date:12/7/2016)... Yorba Linda, Ca (PRWEB) , ... December 07, 2016 , ... ... to attain that funding is with useful, properly analyzed data. The team at Beckman ... generation to address the 'need for speed' and the need to operate in a ...
(Date:12/7/2016)... ... 2016 , ... A quote from Dr. Edward Hallowell, host of CRN International’s ... offer a rare glimpse into the mind of those people with ADHD. , Dr. ... author, has described people with ADHD as having “Ferrari engines for a brain, with ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Eli Lilly and ... the neoMONARCH study of abemaciclib, a cyclin-dependent kinase (CDK) ... of reducing expression of Ki67, a biomarker of cell ... the Phase 2 trial presented during the official press ... (SABCS) evaluated abemaciclib, both alone or in combination with ...
(Date:12/7/2016)... Global Cervical Dysplasia Market: Scope and ... dysplasia market analyzes the current and future prospects ... executive summary, including a market snapshot that provides ... The research is a combination of primary and ... our research efforts along with information collected from ...
(Date:12/7/2016)... REPORT OBJECTIVES The report ... intelligence on a market segment, based on geography. ... in the report. The primary objectives of this ... intelligence through detailed segmentation, 2) market size and ... developments, market situation, trends, 3) detailed analysis of ...
Breaking Medicine Technology: